From the Department of Anesthesiology (H.K., Y.S., T.A., G.S.) Department of Pharmacology (D.N., A.N.), Kagawa University, Kagawa Department of Nephrology, Graduate School of Medicine, Kyoto University, Kyoto (J.N., H.Y., M.Y.) Department of Nephrology, Kumamoto University Graduate School of Medical Sciences, Kumamoto (M.M.) Department of Biochemistry, National Cerebral and Cardiovascular Center Research Institute, Osaka (T.T., K.K.), Japan.
Anesthesiology. 2018 Aug;129(2):296-310. doi: 10.1097/ALN.0000000000002214.
WHAT THIS ARTICLE TELLS US THAT IS NEW: BACKGROUND:: Natriuretic peptides are used, based on empirical observations, in intensive care units as antioliguric treatments. We hypothesized that natriuretic peptides prevent lipopolysaccharide-induced oliguria by activating guanylyl cyclase A, a receptor for natriuretic peptides, in proximal tubules and endothelial cells.
Normal Sprague-Dawley rats and mice lacking guanylyl cyclase A in either endothelial cells or proximal tubular cells were challenged with lipopolysaccharide and assessed for oliguria and intratubular flow rate by intravital imaging with multiphoton microscopy.
Recombinant atrial natriuretic peptide efficiently improved urine volume without changing blood pressure after lipopolysaccharide challenge in rats (urine volume at 4 h, lipopolysaccharide: 0.6 ± 0.3 ml · kg · h; lipopolysaccharide + fluid resuscitation: 4.6 ± 2.0 ml · kg · h; lipopolysaccharide + fluid resuscitation + atrial natriuretic peptide: 9.0 ± 4.8 ml · kg · h; mean ± SD; n = 5 per group). Lipopolysaccharide decreased glomerular filtration rate and slowed intraproximal tubular flow rate, as measured by in vivo imaging. Fluid resuscitation restored glomerular filtration rate but not tubular flow rate. Adding atrial natriuretic peptide to fluid resuscitation improved both glomerular filtration rate and tubular flow rate. Mice lacking guanylyl cyclase A in either proximal tubules or endothelium demonstrated less improvement of tubular flow rate when treated with atrial natriuretic peptide, compared with control mice. Deletion of endothelial, but not proximal tubular, guanylyl cyclase A augmented the reduction of glomerular filtration rate by lipopolysaccharide.
Both endogenous and exogenous natriuretic peptides prevent lipopolysaccharide-induced oliguria by activating guanylyl cyclase A in proximal tubules and endothelial cells.
本文的新发现:背景:基于经验观察,在重症监护病房中使用利钠肽作为抗利尿治疗。我们假设利钠肽通过激活近端肾小管和内皮细胞中利钠肽的受体鸟苷酸环化酶 A 来预防内毒素诱导的少尿。
用内毒素攻击正常的 Sprague-Dawley 大鼠和内皮细胞或近端肾小管细胞中缺乏鸟苷酸环化酶 A 的小鼠,并通过多光子显微镜的活体成像评估少尿和管腔内流速。
重组心钠肽在大鼠内毒素挑战后有效改善尿量而不改变血压(4 小时尿量,内毒素:0.6±0.3ml·kg·h;内毒素+液体复苏:4.6±2.0ml·kg·h;内毒素+液体复苏+心钠肽:9.0±4.8ml·kg·h;均值±SD;每组 n=5)。内毒素降低肾小球滤过率,并通过体内成像测量减慢近段肾小管内流速。液体复苏恢复肾小球滤过率,但不恢复管腔流速。在液体复苏中加入心钠肽可改善肾小球滤过率和管腔流速。与对照小鼠相比,近端肾小管或内皮细胞缺乏鸟苷酸环化酶 A 的小鼠用心钠肽治疗时,管腔流速改善较少。内皮细胞而非近端肾小管的鸟苷酸环化酶 A 的缺失增强了内毒素对肾小球滤过率的降低。
内源性和外源性利钠肽通过激活近端肾小管和内皮细胞中的鸟苷酸环化酶 A 来预防内毒素诱导的少尿。